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Key points
† The effect of propofol on
two EEG-indices (PSI and
BIS) was analysed.
† Seventeen patients were
investigated without
surgical stimulus.
† PSI and BIS predicted
depth of propofol
anaesthesia with a
comparable probability.
† At clinically relevant
propofol concentrations,
PSI was lower than BIS by
10–15 points.
Background. The patient state index (PSI) and the bispectral index (BIS) quantify
anaesthetic depth based on the EEG using different algorithms. We compared both
indices with regard to the prediction of the depth of propofol anaesthesia.
Methods. In 17 patients, propofol was infused until burst suppression occurred and stopped
thereafter until BIS recovered to values above 60. This was repeated; afterwards, patients
were intubated, for subsequent surgery. Without surgical stimulus, PSI and BIS were
measured simultaneously and compared with the estimated effect-site concentrations of
propofol. These were derived from simultaneous pharmacokinetic and -dynamic
modelling in an individual two-stage and a population-based NONMEM approach.
Results. A close sigmoid relationship was observed between the propofol effect-site
concentration and both PSI [coefficient of determination r2¼0.91 (SD 0.05)] and BIS
[r2¼0.92 (0.03)], which was significantly steeper for PSI [g¼2.2 (0.6)] than for BIS [g¼1.8
(0.4)], and reached significantly lower values for PSI [Emax¼0.3 (1.1)] than for BIS
[Emax¼5.3 (6.7)] at maximal propofol concentrations. A significantly smaller ke0 was
obtained for PSI [0.09 (0.03) min21] compared with BIS [0.10 (0.02) min21]. PSI and BIS
correlated significantly with each other (r2¼0.866) and predicted propofol effect-site
concentration with a comparable probability [PK¼0.87 (0.05) and 0.86 (0.05), respectively].
NONMEM revealed E0¼89.3 and 92.3, Emax¼1.9 and 8.6, Ce50¼1.38 and 1.92 mg ml21,
g¼1.6 and 1.48, and ke0¼0.103 and 0.131 min21 as typical values for PSI and BIS,
respectively.
Conclusions. The PSI and the BIS monitors performed equally well in predicting depth of
propofol anaesthesia. However, PSI was lower than BIS by 10–15 points at high propofol
concentrations.
Keywords: depth of anaesthesia; EEG; pharmacodynamics; pharmacokinetics, propofol;
propofol
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Both volatile and i.v. anaesthetics induce characteristic elec-
troencephalographic (EEG) changes, which are used to
assess the depth of anaesthesia. Different parameters have
been evaluated to quantify this effect,1 for example, spectral
edge and median EEG frequency, state and response entropy,
and indices such as the bispectral index (BIS), the Narcotrend
index, and the patient state index (PSI). These indices which
quantify anaesthetic depth using the same range from 100
(awake state) to 0 (deep anaesthesia), however, are based
on different algorithms.1
The PSI monitor records four EEG channels and calculates
the PSI based on the quantitative EEG analysis of the power
within the a, b, d, and u-frequency bands, and also the tem-
poral and spatial gradients occurring among these frequency
bands when changing anaesthetic depth.2
The BIS monitor analyses the EEG frequencies too;
however, it considers not only the power but the phase infor-
mation as well, which are derived from fast Fourier trans-
formation. A process called bispectral analysis investigates
the phase coupling between different EEG frequencies and
contributes to both the BIS and the naming of the monitor
itself.3
Previously, we analysed the performance of the PSI and
BIS monitors to predict the depth of sevoflurane anaesthesia
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and obtained comparable results. Only slight differences
between the monitors were noticed: whereas the BIS
reacted faster to changes in sevoflurane concentrations,
the PSI made a better use of the index range.4
In addition to these previous results obtained by using
a volatile anaesthetic, we performed a study applying an
i.v. drug: the aim of the current study was to analyse the
pharmacodynamic effects of propofol on PSI and BIS and
to compare the performance of both monitors to predict
the depth of propofol anaesthesia.
Methods
After approval of the University of Bonn Ethics Committee
(reference number 203/03) and written informed consent,
we evaluated 17 patients undergoing otorhinolaryngologic
surgery. Age was restricted to 18–65 yr, and ASA physical
status to I or II. Pregnancy and any disease or (current) treat-
ment affecting the central nervous system were exclusion
criteria.
Patients were instructed to fast for 6 h and received mid-
azolam 7.5 mg p.o. 45 min before induction of anaesthesia.
Standard anaesthetic monitoring was applied upon arrival
in the induction room, and mean arterial pressure (MAP)
was measured non-invasively at intervals of 2.5 min. The
forehead skin was cleaned with 70% isopropanol to
improve skin conductance, and both EEG electrodes (Physio-
metrix PSArray2 Sensorw, BIS XP-Sensorw) were applied sub-
sequently according to the manufacturer’s instructions. The
Hospira (formerly Physiometrix) PSA 4000 monitorw
(Hospira Inc., Lake Forest, IL, USA) and the Aspect A-2000
BIS monitorw (version XP, Aspect Medical Systems, Newton,
MA, USA) were used to record the EEG simultaneously and
continuously.
A 14 G venous catheter was inserted into a large forearm
vein and lactated Ringer’s solution was infused at a con-
stant infusion rate of 500 ml h21. Anaesthesia was
induced solely by a continuous propofol 2% infusion at a
rate of 2000 mg h21. The propofol infusion was stopped
(Fig. 1) as soon as substantial burst suppression occurred
(burst suppression rate .60% according to the BIS
monitor) or arterial hypotension occurred (MAP ,60 mm
Hg). After discontinuation of the propofol application,
depth of anaesthesia diminished slowly. When the BIS
recovered to values .60, the propofol infusion was
started again (Fig. 1) at an identical rate of 2000 mg h21
until a burst suppression rate .60% or an MAP ,60 mm
Hg was reached. Thereafter, propofol infusion was discon-
tinued and started again as mentioned above to perform
further cycles of increasing and decreasing propofol
plasma concentration. After a maximum of three cycles—
or sooner if necessary due to the OR management require-
ments—EEG measurements were stopped and patients
received opioids and neuromuscular blocking agents for
subsequent intubation and surgery. Until that time, patients
breathed spontaneously during the entire study period.
Fraction of inspired oxygen was reduced from 1.0 at preox-
ygenation to 0.5 during the study.
PSI (release 3.00.09, averaging time 25 s, PSI value
updated every 1.25 s), BIS (version 4.0, smoothing time 15 s,
BIS value updated every second), and haemodynamic data
(S/5 monitorw, GE Healthcare, Helsinki, Finland) were stored
simultaneously every 5 s using software supplied by the
manufacturer (Aspect: Winlog software; Datex Ohmeda: S/5
Collect software V 4.0).
Arterial propofol plasma concentrations were calculated
using an Excel spreadsheet described by Bruhn and Bouillon5
based on the pharmacokinetic data set published by Schni-
der and colleagues.6 The propofol effect-site concentration
(Ce) was obtained by simultaneous pharmacokinetic–phar-
macodynamic (pk/pd) modelling.7 First, Ce was estimated
using the differential equation:
dCe
dt
= (Cpl − Ce) × ke0
where Cpl is the plasma concentration of propofol, and ke0
denotes the first-order rate constant determining the efflux
from the effect site. In practice, ke0 is approximated until
the hysteresis loop between Ce and the EEG variable (BIS,
PSI) has been collapsed. Secondly, a classic fractional
sigmoid relation between Ce and the EEG effect E (BIS, PSI)
was assumed:8
E = E0 + Emax − E0( ) C
g
e
Cge50 + Cge
( )
where E0 denotes the EEG effect in the absence of propofol
(¼baseline or awake state), and Emax is the EEG value
corresponding to the maximum propofol effect. Ce50
describes the propofol effect-site concentration that causes
50% of the maximum EEG effect, and g quantifies the
slope of the sigmoid relationship between Ce and E.
Pk/pd parameters were determined offline using two
different approaches: in a Fisherian statistics approach (also
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Fig 1 Example of the time course of the experiment: propofol
was given at a constant rate during the shaded periods, resulting
in plasma (Cpl) concentration (dashed green line) and effect-site
(Ce) concentration (dotted pink line). The corresponding BIS
values are shown as a solid blue line.
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known as classic two-stage approach), pk/pd parameters
were first obtained for each individual patient (individual fit)
applying the solver tool of the Excel 2000 software (Microsoft,
Redmond, WA, USA): this tool was used to perform a sigmoid
regression of the EEG effect based on Ce.
4 9 To quantify the
goodness of the sigmoid fit, the coefficient of determination
r2 was calculated as
r2 = 1−
∑
Emeasured − Ecalculated( )2∑
Emeasured − Emeasured
( )2
where Emeasured is the averaged measured EEG effect. ke0 and
the pd parameters E0, Emax, C50, and g were simultaneously
optimized by minimizing the ordinary least squares, which
resulted from the difference between observed and esti-
mated EEG effect. This yielded a collapse of the above-
mentioned hysteresis loop. Subsequently, pk/pd parameters
were averaged among all 17 patients.
In a second Bayesian statistics approach, it was assumed
that a ‘typical value’ for the pk/pd parameters exist within
a given patient population10 (population fit). Furthermore, it
was hypothesized that additional random effects affect
those pk/pd parameters, which are inter- and intra-individual
variabilities. Whereas inter-individual variability reflects true
biologic variability, intra-individual variability can be
regarded as measurement noise or residual error.11 The
NONMEM (‘NONlinear Mixed Effects Modelling’) software11
(version V, GloboMax, Hanover, MD, USA) was used to
perform this approach. ke0 and the pharmacodynamic
parameters were estimated directly (in contrast to the
above-mentioned two-stage approach) without fitting the
pharmokinetic model itself. To do so, the so-called first-order
conditional estimation method was applied.11 Inter-
individual variability was calculated for Ce50 and ke0, and
the intra-individual variability s (residual error) of the EEG
effect (BIS, PSI) was estimated using an additive error
model:11
Eobserved = Eexpected + 1
where Eobserved and Eexpected refer to the observed and pre-
dicted EEG effects, respectively, and 1 is a normally distribu-
ted random variable with mean zero and variance s.2 The
software optimized the pk/pd parameters to obtain a close
agreement between observed and estimated EEG effect: in
statistical terms, NONMEM maximizes the likelihood that
the observed EEG effect would have been observed based
on the propofol Cpl data if the pk/pd parameters were
chosen and the intra- and inter-individual variabilities were
estimated as suggested by NONMEM assuming a certain
(here: sigmoid) EEG effect model.11
For measurement and comparison of the performance of
anaesthetic depth monitors, the prediction probability PK by
which the EEG variable (BIS, PSI) correctly predicted the pro-
pofol effect-site concentration was calculated according to
Smith and colleagues12 applying his Excel software
program PKMACRO. PK itself is a non-parametric measure
ranging between 0 and 1. An anaesthetic depth monitor
that always predicts depth of anaesthesia correctly will
obtain a PK value of 1, whereas a monitor that performs no
better than by (50:50) chance will be characterized by a PK
value of 0.5.12 Since propofol concentration increases as
BIS and PSI decrease, the actual PK value we measure is
12PK. Finally, Pearson’s product-moment correlation coeffi-
cient r and its square r2 (¼coefficient of determination)
were calculated to provide information on the goodness of
the linear fit between PSI and BIS.
Statistical analysis
The study was designed to detect a change in the mean PK
value of 0.075, that is, 75% of the expected standard
deviation (SD) of the PK value of 0.1 (as derived from our
previous study).4 At a desired power of 0.8 and an a of
0.05, 17 patients are required to do so, plus one additional
patient to correct for a possible drop-out.
Statistical analysis was performed using the SigmaStat
software (Jandel Scientific, Erkrath, Germany) applying Stu-
dent’s t-test for paired samples in the case of normal distrib-
uted data. Otherwise, the Wilcoxon signed-rank test was
performed. To comply with multiple comparisons, Bonferro-
ni’s correction was applied and statistical significance was
assumed at P,0.01 accordingly. Data are presented as
mean (SD) for the Fisherian and as typical value for the Baye-
sian approach.
Results
The 17 patients (seven women and 10 men) were 36 (12) yr
old [mean (SD)], had a body weight of 74 (17) kg, a height of
172 (11) cm, and a BMI of 25.0 (4.4) kg m22.
PSI and BIS data from all 17 patients were available for
final data analysis: one-and-a-half cycles of in- and decreas-
ing propofol concentrations were analysed in one patient,
two cycles in nine patients, and three cycles in seven
patients. The endpoint of a burst suppression ratio of 60%
was reached in all patients except for one, in which the pro-
pofol infusion was stopped at a burst suppression rate of 36%
since the endpoint of an MAP ,60 mm Hg was attained.
Individual pk/pd fitting
The pk/pd parameters obtained in the individual patients are
shown in Table 1. Emax was significantly lower (P¼0.007, Wil-
coxon signed-rank test) for PSI [0.3 (1.1)] when compared
with BIS [5.3 (6.7)], and g was significantly higher (P¼0.01,
paired t-test) for PSI [2.18 (0.57)] as for BIS [1.75 (0.41)]. In
addition, a significantly smaller ke0 (P¼0.005, paired t-test)
was observed using the PSI monitor [ke0¼0.088 (0.029)]
when compared with the BIS monitor [ke0¼0.104 (0.024)].
A close sigmoid relationship between Ce and PSI [r
2¼0.91
(0.05)] or BIS [r2¼0.92 (0.03)] was obtained in individual
patients, and the prediction probability of PSI [PK¼0.87
(0.05)] and BIS [PK¼0.86 (0.05)] to predict the propofol
effect-site concentration did not differ statistically from
each other (P¼0.74, paired t-test).
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Population-based pk/pd fitting
The sigmoid relationship between the propofol effect-site
concentration and the PSI and BIS as obtained by
population-based fitting is shown in Figures 2 and 3, respect-
ively. An intra-individual variability (residual error) of s¼7.7
and 6.4 was obtained for PSI and BIS, respectively
(Table 1). The typical value of Emax was smaller for PSI (1.9)
as for BIS (8.6), whereas the other pk/pd parameters were
comparable between the monitors. The recommended
intraoperative range for PSI (50–25) and BIS (60–40) corre-
sponded to propofol effect-site concentrations of 1.2–2.6
and 1.4–2.7 mg ml21, respectively (Fig. 4).
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Fig 4 For the recommended ranges (shown as bars on the left
and right ordinate) of the PSI (25–50) and the BIS (40–60), the
corresponding propofol effect-site concentration site ranges (dis-
played as bars on the abscissa) are shown. The relation is based
on the pharmacodynamic effect of propofol on BIS (blue line) and
PSI (dotted green line) for the ‘typical patient’ as revealed by
NONMEM.
Table 1 Pharmacokinetic and -dynamic parameters in comparison between PSI and BIS. Parameters were obtained by individual and
population-based fitting. A sigmoid relationship between propofol effect-site concentration and EEG effect (BIS and PSI) was assumed. Data are
expressed as mean (SD) for the individual fits and as typical value (SD) for the population fit. *P,0.01 vs BIS. PSI, patient state index; BIS,
bispectral index; E0, EEG effect without anaesthesia; Emax, EEG effect corresponding to maximum drug effect; Ce50, propofol effect-site
concentration that caused 50% of the maximum EEG effect; g, slope of the sigmoid relationship; ke0, effect-site efflux constant; r
2, coefficient of
determination; PK, prediction probability by which the EEG variable (BIS, PSI) correctly predicted the propofol effect-site concentration; s,
intra-individual EEG variability (¼residual error)
Fit PSI BIS
Individual Population Individual Population
E0 86.9 (12.3) 89.3 92.0 (7.0) 92.3
Emax 0.3 (1.1) 1.9 5.3 (6.7)* 8.6
Ce50 (mg ml
21) 1.87 (0.78) 1.38 (0.86) 1.94 (0.52) 1.92 (0.82)
g 2.18 (0.57) 1.60 1.75 (0.41)* 1.48
ke0 (min
21) 0.088 (0.029) 0.103 (0.210) 0.104 (0.024)* 0.131 (0.206)
r2 0.913 (0.054) 0.922 (0.033)
PK 0.867 (0.053) 0.863 (0.051)
s 7.7 6.4
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Fig 2 The relationship between the propofol effect-site concen-
tration and PSI is shown for the ‘typical patient’ as obtained by
population fit using NONMEM. The residual data of the individual
patients are marked by blue circles.
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Fig 3 The response of the BIS to changes in the propofol effect-
site concentration is displayed for the ‘typical patient’ as revealed
by population fit using the NONMEM software. The blue triangles
indicate the residual data of the individual patients.
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Correlation between BIS and PSI
A close and significant correlation between BIS and PSI was
found (r2¼0.866, P,0.001). For PSI values between 25 and
50—the recommended range for general anaesthesia—
44% of corresponding BIS data were within the range of
40–60, whereas for the recommended BIS range between
40 and 60, 69% of corresponding PSIs were within the
range of 25–50.
Discussion
Both the PSI and BIS monitors performed equally well
[PK¼0.87 (0.05) for PSI and 0.86 (0.05) for BIS, respectively]
in predicting the estimated propofol effect-site concen-
trations. According to the definition of the prediction prob-
ability PK,
12 this means that if one changes the depth of
propofol anaesthesia in our data set a hundred times, the
PSI and BIS would correctly indicate this change in 87 and
86 cases, respectively. These reasonably high values were
obtained using the i.v. anaesthetic propofol and exceed
those PK values reported in our previous study [PK¼0.80
(0.11) for PSI and 0.79 (0.09) for BIS], in which we used the
volatile anaesthetic sevoflurane instead.4
Both monitors differ in their algorithm. The PSI revealed
generally lower index values than the BIS (Fig. 4), especially
at high or even maximal concentrations, as expressed by
the parameter Emax: we had already observed this effect in
our previous study4 using sevoflurane [Emax¼1.3 (4.3) for
PSI and 7.9 (12.1) for BIS] and confirmed this finding using
propofol this time [Emax¼0.3 (1.1) for PSI and 5.3 (6.7) for
BIS]. Consistently, the manufacturer of the PSI recommends
a range of 25–50 for general anaesthesia,13 which is lower
than the recommended range for BIS14 (40–60, Fig. 4).
We reported a higher efflux site constant ke0 (that is a
lower efflux site half-time t1/2ke0¼ln 2/ke0) for BIS
[ke0¼0.24 (0.15) min21] when compared with PSI [ke0¼0.13
(0.08) min21] during sevoflurane anaesthesia and attributed
this to differences in time lag, calculation time, and aver-
aging time between the monitors. However, this significant
difference in ke0 (almost) disappeared when using propofol
[ke0¼0.10 (0.02) min21 for BIS and ke0¼0.09 (0.03) min21
for PSI]. We assume that the mentioned differences
between monitors in time lag, calculation, and averaging
time are clinically important only when using an agent
with a fast pharmacokinetic such as sevoflurane (t1/2 ke0≈4
min) but become irrelevant when using an anaesthetic
with a slower kinetic such as propofol (t1/2 ke0≈7 min).
The slope g of the sigmoid relationship between propofol
effect-site concentration and EEG effect was significantly
steeper for PSI [g¼2.2 (0.6)] when compared with BIS
[g¼1.8 (0.4)], which is a mathematical consequence of the
small difference in E0 but large (and significant) difference
in Emax (Fig. 4). This difference appeared in the previous sevo-
flurane study as well [g¼2.1 (1.4) for PSI and g¼1.8 (0.8) for
BIS], but was statistically not significant.4
We applied the PK model proposed by Schnider and col-
leagues,6 since it adjusts doses and infusion rates to both
age and weight, whereas the alternative PK model published
by Marsh and colleagues15 considers weight only. However, it
should be noted that ‘there is little conclusive evidence to
demonstrate the superiority of any particular model’.16 Appli-
cation of the Marsh instead of the Schnider model would
have yielded similar r2 and PK values, since it would have
affected both the BIS and the PSI monitors in an equal
manner. In addition, major and clinical significant differ-
ences between the Marsh and the Schnider models are
expected to occur, especially in elderly and obese patients;16
however, neither condition existed in our study population.
All patients received midazolam as premedication. Since
benzodiazepines alter the EEG,17 this might have influenced
the propofol concentration–effect curve. However, the
concentration of midazolam necessary to cause EEG changes
(.100 ng ml21)17 exceed the peak plasma concentration (35
ng ml21, as extrapolated from Greenblatt and colleagues)18
after oral administration of 7.5 mg by a factor of three.
Since this is the first study, to our knowledge, that ana-
lyses the pharmacodynamic effect of propofol on PSI by
application of a sigmoid pk/pd model, there are no other
PSI pk/pd studies to refer to. However, with regard to the
BIS during propofol anaesthesia, the following observations
are noteworthy when comparing the pk/pd parameters of
our study with the results of other investigators (Table 2):
Emax was lower in our study, indicating that we achieved
deeper levels of propofol anaesthesia. In addition, we
observed a lower Ce50 (1.9 mg ml
21) which appears low
from a clinical standpoint but is explained by the fact that
the study was performed in the absence of any kind of stimu-
lus. Thus, relatively low concentrations of propofol were
required to achieve a level of general anaesthesia. Finally,
the effect-site efflux constant ke0 was lower. The pk/pd par-
ameters described in the literature (Table 2) vary to a con-
siderable amount reflecting the given inter-individual
variability, which is an inherent feature of complex biological
systems such as the human being.
To take this variability in pk/pd parameters into account,
we performed a Bayesian statistics approach in addition to
the classic Fisherian statistics: we applied the NONMEM soft-
ware which estimated a pk/pd model based on fixed effects
(the so-called ‘typical values’ in NONMEM parlance) and
random effects, which are differentiated into effects due to
inter- and intra-individual variabilities.11 As demonstrated
in Table 1, the typical values of the pk/pd parameters
which characterize a representative patient within a given
population differ only slightly from the mean values obtained
using the two-stage approach. However, the inter-individual
variability of Ce50 and ke0 is considerably high, whereas the
intra-individual variability s of the PSI (+7.7 index points)
and BIS (+6.4 index points) is low. Thus, our results
confirm the general rule, that pharmacodynamic variability
is pronounced (usually exceeding pharmacokinetic variabil-
ity), and that inter-individual differences are large, whereas
intra-individual differences are much smaller.19
We observed a close sigmoid relationship (r2¼0.91 for PSI
and 0.92 for BIS) between propofol effect-site concentration
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and EEG effect (i.e. BIS and PSI). In the absence of a gold-
standard defining depth of anaesthesia, effect-site concen-
tration is a widely accepted surrogate parameter.20 – 23 Con-
sequently, both the BIS and the PSI monitors can be
regarded as monitors of depth of anaesthesia.
We noticed a close and significant linear correlation between
PSI and BIS (r2¼0.87) during propofol anaesthesia which
exceeded our previous findings4 obtained using sevoflurane
(r2¼0.75). Nevertheless, we only found a poor agreement
between the recommended ranges for PSI (25–50) and BIS
(40–60), so that index values—which were within the rec-
ommended range in one monitor—were outside the range in
the other monitor, as was previously reported by Schneider
and colleagues.24 Other authors24–26 reported a rather
modest correlation between PSI and BIS with a coefficient of
determination r2 ranging between 0.4424 and 0.72.26 However,
their data were based on a previous version of either the electro-
des or the monitors, or used a different hypnotic regimen.
PSI and BIS have already been compared in the past and
disagreeing assessments were published: PSI and BIS per-
formed equally well in predicting unconsciousness26 [receiver
operating characteristics, ROC¼0.98 (0.05) for PSI and 0.97
(0.05) for BIS] and detecting awareness27 [PK¼0.69 (0.03)
for PSI and 0.68 (0.03) for BIS]; however, the latter ability
was deemed to be nonetheless insufficient.27 In contrast,
PSI was found to be superior to BIS in detecting conscious-
ness [ROC¼0.95 (0.04) for PSI and ROC¼0.79 (0.04) for BIS]
according to Chen and colleagues,28 and Adesanya and col-
leagues25 reported that BIS was consistently better in pre-
dicting oversedation than the PSI (area under the
curve¼0.92 for BIS and 0.78 for PSI).
The PSI was approved in 2002 and has been evaluated
since then in 15 publications (retrieval at PubMed on
October 15, 2009). In contrast, the BIS has already been
approved in 1996, subjected to 1417 publications (retrieval
at PubMed on October 15, 2009) and applied to more than
34 million patients (according to manufacturer’s infor-
mation). Hence, BIS technology is thought to be the most
validated form of depth of anaesthesia monitoring so far.
We conclude that both the PSI and the BIS monitors
predict depth of propofol anaesthesia with a similar and suf-
ficient high probability. The major difference between the
two monitors (besides their algorithm) refers to the fact
that PSI values were lower than the BIS values by 10–15
index points resulting in a lower recommended range (25
to 50 for PSI, and 40 to 60 for BIS) for general anaesthesia.
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